Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure
<p>Abstract</p> <p>The human ATP-binding cassette (ABC) transporters ABCB1, ABCC4 and ABCC5 are involved in resistance to chemotherapeutic agents. Here we present molecular models of ABCB1, ABCC4 and ABCC5 by homology based on a wide open inward-facing conformation of <it>Esc...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | Theoretical Biology and Medical Modelling |
Online Access: | http://www.tbiomed.com/content/6/1/20 |
id |
doaj-73579b45ec2f4bbd8e78c0f807364ae1 |
---|---|
record_format |
Article |
spelling |
doaj-73579b45ec2f4bbd8e78c0f807364ae12020-11-24T22:59:56ZengBMCTheoretical Biology and Medical Modelling1742-46822009-09-01612010.1186/1742-4682-6-20Binding site of ABC transporter homology models confirmed by ABCB1 crystal structureSager GeorgSylte IngebrigtRavna Aina W<p>Abstract</p> <p>The human ATP-binding cassette (ABC) transporters ABCB1, ABCC4 and ABCC5 are involved in resistance to chemotherapeutic agents. Here we present molecular models of ABCB1, ABCC4 and ABCC5 by homology based on a wide open inward-facing conformation of <it>Escherichia coli </it>MsbA, which were constructed in order to elucidate differences in the electrostatic and molecular features of their drug recognition conformations. As a quality assurance of the methodology, the ABCB1 model was compared to an ABCB1 X-ray crystal structure, and with published cross-linking and site directed mutagenesis data of ABCB1. Amino acids Ile306 (TMH5), Ile340 (TMH6), Phe343 (TMH6), Phe728 (TMH7), and Val982 (TMH12), form a putative substrate recognition site in the ABCB1 model, which is confirmed by both the ABCB1 X-ray crystal structure and the site-directed mutagenesis studies. The ABCB1, ABCC4 and ABCC5 models display distinct differences in the electrostatic properties of their drug recognition sites.</p> http://www.tbiomed.com/content/6/1/20 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sager Georg Sylte Ingebrigt Ravna Aina W |
spellingShingle |
Sager Georg Sylte Ingebrigt Ravna Aina W Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure Theoretical Biology and Medical Modelling |
author_facet |
Sager Georg Sylte Ingebrigt Ravna Aina W |
author_sort |
Sager Georg |
title |
Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure |
title_short |
Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure |
title_full |
Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure |
title_fullStr |
Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure |
title_full_unstemmed |
Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure |
title_sort |
binding site of abc transporter homology models confirmed by abcb1 crystal structure |
publisher |
BMC |
series |
Theoretical Biology and Medical Modelling |
issn |
1742-4682 |
publishDate |
2009-09-01 |
description |
<p>Abstract</p> <p>The human ATP-binding cassette (ABC) transporters ABCB1, ABCC4 and ABCC5 are involved in resistance to chemotherapeutic agents. Here we present molecular models of ABCB1, ABCC4 and ABCC5 by homology based on a wide open inward-facing conformation of <it>Escherichia coli </it>MsbA, which were constructed in order to elucidate differences in the electrostatic and molecular features of their drug recognition conformations. As a quality assurance of the methodology, the ABCB1 model was compared to an ABCB1 X-ray crystal structure, and with published cross-linking and site directed mutagenesis data of ABCB1. Amino acids Ile306 (TMH5), Ile340 (TMH6), Phe343 (TMH6), Phe728 (TMH7), and Val982 (TMH12), form a putative substrate recognition site in the ABCB1 model, which is confirmed by both the ABCB1 X-ray crystal structure and the site-directed mutagenesis studies. The ABCB1, ABCC4 and ABCC5 models display distinct differences in the electrostatic properties of their drug recognition sites.</p> |
url |
http://www.tbiomed.com/content/6/1/20 |
work_keys_str_mv |
AT sagergeorg bindingsiteofabctransporterhomologymodelsconfirmedbyabcb1crystalstructure AT sylteingebrigt bindingsiteofabctransporterhomologymodelsconfirmedbyabcb1crystalstructure AT ravnaainaw bindingsiteofabctransporterhomologymodelsconfirmedbyabcb1crystalstructure |
_version_ |
1725643266551971840 |